Global burden of urologic cancers, 1990–2013

GW Dy, JL Gore, MH Forouzanfar, M Naghavi… - European urology, 2017 - Elsevier
Context Kidney, prostate, and bladder cancers increase with age and are influenced partly
by modifiable risk factors. Urological cancer rates may increase substantially amid a …

Prostate cancer treatment–China's perspective

J Liu, L Dong, Y Zhu, B Dong, J Sha, HH Zhu, J Pan… - Cancer letters, 2022 - Elsevier
Prostate cancer (PCa) incidence and mortality have rapidly increased in China. Notably,
unique epidemiological characteristics of PCa are found in the Chinese PCa population …

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

F Bray, J Ferlay, I Soerjomataram… - CA: a cancer journal …, 2018 - Wiley Online Library
This article provides a status report on the global burden of cancer worldwide using the
GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International …

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

H Sung, J Ferlay, RL Siegel… - CA: a cancer journal …, 2021 - Wiley Online Library
This article provides an update on the global cancer burden using the GLOBOCAN 2020
estimates of cancer incidence and mortality produced by the International Agency for …

Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries

MCS Wong, WB Goggins, HHX Wang, FDH Fung… - European urology, 2016 - Elsevier
Abstract Background Prostate cancer (PCa) is a leading cause of mortality and morbidity
globally, but its specific geographic patterns and temporal trends are under-researched …

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

F Bray, M Laversanne, H Sung, J Ferlay… - CA: a cancer journal …, 2024 - Wiley Online Library
This article presents global cancer statistics by world region for the year 2022 based on
updated estimates from the International Agency for Research on Cancer (IARC). There …

Next generation NIR fluorophores for tumor imaging and fluorescence-guided surgery: A review

A Haque, MSH Faizi, JA Rather, MS Khan - Bioorganic & medicinal …, 2017 - Elsevier
Cancer is a group of diseases responsible for the major causes of mortality and morbidity
among people of all ages. Even though medical sciences have made enormous growth …

Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies

M Lucas, I Jansen, CD Savci-Heijink, SL Meijer… - Virchows Archiv, 2019 - Springer
Histopathologic grading of prostate cancer using Gleason patterns (GPs) is subject to a
large inter-observer variability, which may result in suboptimal treatment of patients. With the …

Prostate cancer survival in the United States by race and stage (2001‐2009): findings from the CONCORD‐2 study

CB Steele, J Li, B Huang, HK Weir - Cancer, 2017 - Wiley Online Library
BACKGROUND The 5‐year relative survival for prostate cancers diagnosed between 1990
and 1994 in the United States was very high (92%); however, survival in black males was …

The Lancet Commission on prostate cancer: planning for the surge in cases

ND James, I Tannock, J N'Dow, F Feng, S Gillessen… - The Lancet, 2024 - thelancet.com
Executive summary Prostate cancer is the most common cancer in men in 112 countries,
and accounts for 15% of cancers. In this Commission, we report projections of prostate …